U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Nutrex Research, Inc. - Close Out Letter 8/18/17
  1. Compliance Actions and Activities

CLOSEOUT LETTER

Nutrex Research, Inc. Aug 18, 2017

Nutrex Research, Inc. - Close Out Letter 8/18/17


Nutrex Research, Inc.

 

  

Black HHS-Blue FDA Logo

 

5001 Campus Drive
College Park, MD 20740 

 
 

August 18, 2017

Mr. Jens Ingenohl
Nutrex Research Incorporated
579 South Econ Circle
Oviedo, FL 32765

Dear Mr. Ingenohl:

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter # 447322, issued April 24, 2015. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Latasha A. Robinson
Branch Chief
Dietary Supplements and Labeling Assessment Branch
Division of Enforcement
Office of Compliance
Center for Food Safety and Applied Nutrition